Maša Alečković

7PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 16, 2025
Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial.

Sangeetha Srinivasan, Nathan A Yee, Maša Alečković

|Sep 07, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.

Maša Alečković, Zheqi Li, Ningxuan Zhou

|Dec 08, 2022
Breast cancer prevention by short-term inhibition of TGFβ signaling.

Maša Alečković, Simona Cristea, Carlos R Gil Del Alcazar

|Nov 21, 2022
JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.

Laura E Stevens, Guillermo Peluffo, Xintao Qiu

|Apr 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer.

Carlos R Gil Del Alcazar, Anne Trinh, Maša Alečković

Pageof 2